Vitiligo Extent Tensity Index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo

Amir Feily, Amir Feily

Abstract

Although skin is the largest organ of the body, there are no standardized reproducible methods for assessing severity of many skin diseases. Due to lack of consensus, methods of assessment and inexistence of precise scoring system, there is no application for vitiligo estimation in real practice. In this paper the author describes VETI score as a new treatment evaluation criteria and severity assessment method for vitiligo. This new tool, as does the PASI score in psoriasis, may be able to produce a constant and reproducible number and to help clinical research on vitiligo patients. Additionally it has a potential to be a source of any computed application for researchers working on vitiligo patients.

Keywords: assessment criteria; score; vitiligo.

Figures

Figure 1.
Figure 1.
Rule of nines in burn assessment. (Copyright: ©2014 Feily.)
Figure 2.
Figure 2.
Hypopigmentation (including trichrome, and homogeneous lighter pigmentation). (Copyright: ©2014 Feily.)
Figure 3.
Figure 3.
Complete depigmentation with black hair and perifollicular pigmentation. (Copyright: ©2014 Feily.)
Figure 4.
Figure 4.
Complete depigmentation with black hair and without perifollicular pigmentation. (Copyright: ©2014 Feily.)
Figure 5.
Figure 5.
Complete depigmentation with compound of white and black hair with/without perifollicular pigmentation. (Copyright: ©2014 Feily.
Figure 6.
Figure 6.
Complete depigmentation plus significant hair whitening. The area where hair does not exist normally, as in the extremities, is very resistant to treatment and placed in grade 5. (Copyright: ©2014 Feily.)

References

    1. Bhor U, Pande S. Scoring systems in dermatology. Indian J Dermatol Venereol Leprol. 2006;72:315–21.
    1. Pfütze M, Niedermeier A, Hertl M, Eming R. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Eur J Dermatol. 2007;17:4–11.
    1. Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo, using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140:677–683.
    1. Taïeb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20:27–35.
    1. PASI Calculator. Psoriasis Area Severity Index (PASI) Calculator (1.7.1). Accessed December 30, 2013.
    1. Wong PC, Leung YY, Li EK, Tam LS. Measuring disease activity in psoriatic arthritis. Int J Rheumatol. 2012;2012:839425.
    1. Fredriksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatologica. 1978;157:238–44.
    1. Benzekri L, Ezzedine K, Gauthier Y. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy. Br J Dermatol. 2013;168:1143–6.
    1. Aydin F, Senturk N, Sahin B, et al. A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques. Eur J Dermatol. 2007;17:30–2.
    1. Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135:407–13.
    1. Wachtel TL, Berry CC, Wachtel EE, Frank HA. The inter-rater reliability of estimating the size of burns from various burn area chart drawings. Burns. 2000;26:156–70.
    1. Feily A, Baktash D, Mohebbipour A, Feily A. Potential advantages of simvastatin as a novel anti-vitiligo arsenal. Eur Rev Med Pharmacol Sci. 2013;17:1982–3.
    1. Feily A, Namazi MR. Silymarin as a potential novel addition to the limited anti-vitiligo weaponry: an untested hypothesis. Int J Clin Pharmacol Ther. 2011;49:467–8.
    1. Kawakami T, Hashimoto T. Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatol Res Pract. 2011;2011:750342.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner